
### [NCIT:C3871](http://purl.obolibrary.org/obo/NCIT_C3871)
**Label:** Nasopharyngeal Carcinoma

**Subclasses:** [NCIT:C7920](http://purl.obolibrary.org/obo/NCIT_C7920) (Stage II Nasopharyngeal Carcinoma AJCC v6), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C6036](http://purl.obolibrary.org/obo/NCIT_C6036) (Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C8230](http://purl.obolibrary.org/obo/NCIT_C8230) (Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma), [NCIT:C8231](http://purl.obolibrary.org/obo/NCIT_C8231) (Recurrent Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C88983](http://purl.obolibrary.org/obo/NCIT_C88983) (Stage III Nasopharyngeal Carcinoma AJCC v7), [NCIT:C88982](http://purl.obolibrary.org/obo/NCIT_C88982) (Stage II Nasopharyngeal Carcinoma AJCC v7), [NCIT:C132818](http://purl.obolibrary.org/obo/NCIT_C132818) (Stage II Nasopharyngeal Carcinoma AJCC v8), [NCIT:C88981](http://purl.obolibrary.org/obo/NCIT_C88981) (Stage I Nasopharyngeal Carcinoma AJCC v7), [NCIT:C132819](http://purl.obolibrary.org/obo/NCIT_C132819) (Stage III Nasopharyngeal Carcinoma AJCC v8), [NCIT:C91244](http://purl.obolibrary.org/obo/NCIT_C91244) (Nasopharyngeal Carcinoma by AJCC v7 Stage), [NCIT:C88984](http://purl.obolibrary.org/obo/NCIT_C88984) (Stage IV Nasopharyngeal Carcinoma AJCC v7), [NCIT:C132816](http://purl.obolibrary.org/obo/NCIT_C132816) (Nasopharyngeal Carcinoma by AJCC v8 Stage), [NCIT:C132817](http://purl.obolibrary.org/obo/NCIT_C132817) (Stage I Nasopharyngeal Carcinoma AJCC v8), [NCIT:C54400](http://purl.obolibrary.org/obo/NCIT_C54400) (Nasopharyngeal Papillary Adenocarcinoma), [NCIT:C8229](http://purl.obolibrary.org/obo/NCIT_C8229) (Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C132820](http://purl.obolibrary.org/obo/NCIT_C132820) (Stage IV Nasopharyngeal Carcinoma AJCC v8), [NCIT:C8227](http://purl.obolibrary.org/obo/NCIT_C8227) (Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8228](http://purl.obolibrary.org/obo/NCIT_C8228) (Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8225](http://purl.obolibrary.org/obo/NCIT_C8225) (Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C7992](http://purl.obolibrary.org/obo/NCIT_C7992) (Nasopharyngeal Keratinizing Squamous Cell Carcinoma), [NCIT:C8226](http://purl.obolibrary.org/obo/NCIT_C8226) (Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8223](http://purl.obolibrary.org/obo/NCIT_C8223) (Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C54360](http://purl.obolibrary.org/obo/NCIT_C54360) (Nasopharyngeal Basaloid Squamous Cell Carcinoma), [NCIT:C8224](http://purl.obolibrary.org/obo/NCIT_C8224) (Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C7395](http://purl.obolibrary.org/obo/NCIT_C7395) (Stage I Nasopharyngeal Carcinoma AJCC v6), [NCIT:C7373](http://purl.obolibrary.org/obo/NCIT_C7373) (Nasopharyngeal Nonkeratinizing Carcinoma), [NCIT:C8023](http://purl.obolibrary.org/obo/NCIT_C8023) (Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C8222](http://purl.obolibrary.org/obo/NCIT_C8222) (Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C7397](http://purl.obolibrary.org/obo/NCIT_C7397) (Stage IV Nasopharyngeal Carcinoma AJCC v6), [NCIT:C9099](http://purl.obolibrary.org/obo/NCIT_C9099) (Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C7396](http://purl.obolibrary.org/obo/NCIT_C7396) (Stage III Nasopharyngeal Carcinoma AJCC v6), [NCIT:C9240](http://purl.obolibrary.org/obo/NCIT_C9240) (Recurrent Nasopharynx Carcinoma), [NCIT:C90522](http://purl.obolibrary.org/obo/NCIT_C90522) (Nasopharyngeal Carcinoma by AJCC v6 Stage), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40383](http://purl.obolibrary.org/obo/NCIT_C40383) (Breast Apocrine Adenoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40362](http://purl.obolibrary.org/obo/NCIT_C40362) (Low Grade Adenosquamous Breast Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40358](http://purl.obolibrary.org/obo/NCIT_C40358) (Squamous Cell Breast Carcinoma, Spindle Cell Variant))) 37.63%


